Cargando…
(18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
BACKGROUND: Quantitative image analysis based on radiomic feature extraction is an emerging field for survival prediction in oncological patients. (18)F-Fluorethyltyrosine positron emission tomography ((18)F-FET PET) provides important diagnostic and grading information for brain tumors, but data on...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719240/ https://www.ncbi.nlm.nih.gov/pubmed/36461120 http://dx.doi.org/10.1186/s13014-022-02164-6 |
_version_ | 1784843277339459584 |
---|---|
author | Wiltgen, Tun Fleischmann, Daniel F. Kaiser, Lena Holzgreve, Adrien Corradini, Stefanie Landry, Guillaume Ingrisch, Michael Popp, Ilinca Grosu, Anca L. Unterrainer, Marcus Bartenstein, Peter Parodi, Katia Belka, Claus Albert, Nathalie Niyazi, Maximilian Riboldi, Marco |
author_facet | Wiltgen, Tun Fleischmann, Daniel F. Kaiser, Lena Holzgreve, Adrien Corradini, Stefanie Landry, Guillaume Ingrisch, Michael Popp, Ilinca Grosu, Anca L. Unterrainer, Marcus Bartenstein, Peter Parodi, Katia Belka, Claus Albert, Nathalie Niyazi, Maximilian Riboldi, Marco |
author_sort | Wiltgen, Tun |
collection | PubMed |
description | BACKGROUND: Quantitative image analysis based on radiomic feature extraction is an emerging field for survival prediction in oncological patients. (18)F-Fluorethyltyrosine positron emission tomography ((18)F-FET PET) provides important diagnostic and grading information for brain tumors, but data on its use in survival prediction is scarce. In this study, we aim at investigating survival prediction based on multiple radiomic features in glioblastoma patients undergoing radio(chemo)therapy. METHODS: A dataset of 37 patients with glioblastoma (WHO grade 4) receiving radio(chemo)therapy was analyzed. Radiomic features were extracted from pre-treatment (18)F-FET PET images, following intensity rebinning with a fixed bin width. Principal component analysis (PCA) was applied for variable selection, aiming at the identification of the most relevant features in survival prediction. Random forest classification and prediction algorithms were optimized on an initial set of 25 patients. Testing of the implemented algorithms was carried out in different scenarios, which included additional 12 patients whose images were acquired with a different scanner to check the reproducibility in prediction results. RESULTS: First order intensity variations and shape features were predominant in the selection of most important radiomic signatures for survival prediction in the available dataset. The major axis length of the (18)F-FET-PET volume at tumor to background ratio (TBR) 1.4 and 1.6 correlated significantly with reduced probability of survival. Additional radiomic features were identified as potential survival predictors in the PTV region, showing 76% accuracy in independent testing for both classification and regression. CONCLUSIONS: (18)F-FET PET prior to radiation provides relevant information for survival prediction in glioblastoma patients. Based on our preliminary analysis, radiomic features in the PTV can be considered a robust dataset for survival prediction. |
format | Online Article Text |
id | pubmed-9719240 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97192402022-12-04 (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy Wiltgen, Tun Fleischmann, Daniel F. Kaiser, Lena Holzgreve, Adrien Corradini, Stefanie Landry, Guillaume Ingrisch, Michael Popp, Ilinca Grosu, Anca L. Unterrainer, Marcus Bartenstein, Peter Parodi, Katia Belka, Claus Albert, Nathalie Niyazi, Maximilian Riboldi, Marco Radiat Oncol Research BACKGROUND: Quantitative image analysis based on radiomic feature extraction is an emerging field for survival prediction in oncological patients. (18)F-Fluorethyltyrosine positron emission tomography ((18)F-FET PET) provides important diagnostic and grading information for brain tumors, but data on its use in survival prediction is scarce. In this study, we aim at investigating survival prediction based on multiple radiomic features in glioblastoma patients undergoing radio(chemo)therapy. METHODS: A dataset of 37 patients with glioblastoma (WHO grade 4) receiving radio(chemo)therapy was analyzed. Radiomic features were extracted from pre-treatment (18)F-FET PET images, following intensity rebinning with a fixed bin width. Principal component analysis (PCA) was applied for variable selection, aiming at the identification of the most relevant features in survival prediction. Random forest classification and prediction algorithms were optimized on an initial set of 25 patients. Testing of the implemented algorithms was carried out in different scenarios, which included additional 12 patients whose images were acquired with a different scanner to check the reproducibility in prediction results. RESULTS: First order intensity variations and shape features were predominant in the selection of most important radiomic signatures for survival prediction in the available dataset. The major axis length of the (18)F-FET-PET volume at tumor to background ratio (TBR) 1.4 and 1.6 correlated significantly with reduced probability of survival. Additional radiomic features were identified as potential survival predictors in the PTV region, showing 76% accuracy in independent testing for both classification and regression. CONCLUSIONS: (18)F-FET PET prior to radiation provides relevant information for survival prediction in glioblastoma patients. Based on our preliminary analysis, radiomic features in the PTV can be considered a robust dataset for survival prediction. BioMed Central 2022-12-02 /pmc/articles/PMC9719240/ /pubmed/36461120 http://dx.doi.org/10.1186/s13014-022-02164-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wiltgen, Tun Fleischmann, Daniel F. Kaiser, Lena Holzgreve, Adrien Corradini, Stefanie Landry, Guillaume Ingrisch, Michael Popp, Ilinca Grosu, Anca L. Unterrainer, Marcus Bartenstein, Peter Parodi, Katia Belka, Claus Albert, Nathalie Niyazi, Maximilian Riboldi, Marco (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy |
title | (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy |
title_full | (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy |
title_fullStr | (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy |
title_full_unstemmed | (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy |
title_short | (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy |
title_sort | (18)f-fet pet radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719240/ https://www.ncbi.nlm.nih.gov/pubmed/36461120 http://dx.doi.org/10.1186/s13014-022-02164-6 |
work_keys_str_mv | AT wiltgentun 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT fleischmanndanielf 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT kaiserlena 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT holzgreveadrien 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT corradinistefanie 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT landryguillaume 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT ingrischmichael 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT poppilinca 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT grosuancal 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT unterrainermarcus 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT bartensteinpeter 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT parodikatia 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT belkaclaus 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT albertnathalie 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT niyazimaximilian 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy AT riboldimarco 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy |